SARS-CoV-2 Omicron Subvariants Do Not Differ Much in Binding Affinity to Human ACE2 : A Molecular Dynamics Study

The emergence of the variant of concern Omicron (B.1.1.529) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exacerbates the COVID-19 pandemic due to its high contagious ability. Studies have shown that the Omicron binds human ACE2 more strongly than the wild type. The prevalence of Omicron in new cases of COVID-19 promotes novel lineages with improved receptor binding affinity and immune evasion. To shed light on this open problem, in this work, we investigated the binding free energy of the receptor binding domain of the Omicron lineages BA.2, BA.2.3.20, BA.3, BA4/BA5, BA.2.75, BA.2.75.2, BA.4.6, XBB.1, XBB.1.5, BJ.1, BN.1, BQ.1.1, and CH.1.1 to human ACE2 using all-atom molecular dynamics simulation and the molecular mechanics Poisson-Boltzmann surface area method. The results show that these lineages have increased binding affinity compared to the BA.1 lineage, and BA.2.75 and BA.2.75.2 subvariants bind ACE2 more strongly than others. However, in general, the binding affinities of the Omicron lineages do not differ significantly from each other. The electrostatic force dominates over the van der Waals force in the interaction between Omicron lineages and human cells. Based on our results, we argue that viral evolution does not further improve the affinity of SARS-CoV-2 for ACE2 but may increase immune evasion.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:128

Enthalten in:

The journal of physical chemistry. B - 128(2024), 14 vom: 11. Apr., Seite 3340-3349

Sprache:

Englisch

Beteiligte Personen:

Nguyen, Hoang Linh [VerfasserIn]
Nguyen, Thai Quoc [VerfasserIn]
Li, Mai Suan [VerfasserIn]

Links:

Volltext

Themen:

Angiotensin-Converting Enzyme 2
EC 3.4.17.23
Journal Article

Anmerkungen:

Date Completed 12.04.2024

Date Revised 25.04.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1021/acs.jpcb.3c06270

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM370539621